Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HUMALOG LISPRO Cause Urinary tract infection? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Urinary tract infection have been filed in association with HUMALOG LISPRO. This represents 1.2% of all adverse event reports for HUMALOG LISPRO.

5
Reports of Urinary tract infection with HUMALOG LISPRO
1.2%
of all HUMALOG LISPRO reports
0
Deaths
4
Hospitalizations

How Dangerous Is Urinary tract infection From HUMALOG LISPRO?

Of the 5 reports, 4 (80.0%) required hospitalization.

Is Urinary tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMALOG LISPRO. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does HUMALOG LISPRO Cause?

Blood glucose increased (172) Blood glucose decreased (46) Diabetic ketoacidosis (46) Drug ineffective (29) Malaise (28) Hypoglycaemia (25) Fall (23) Blindness (19) Incorrect dose administered (19) Drug dose omission (18)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which HUMALOG LISPRO Alternatives Have Lower Urinary tract infection Risk?

HUMALOG LISPRO vs HUMALOG LISPRO, NPL HUMALOG LISPRO vs HUMAN C1-ESTERASE INHIBITOR HUMALOG LISPRO vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HUMALOG LISPRO vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMALOG LISPRO vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN

Related Pages

HUMALOG LISPRO Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection HUMALOG LISPRO Demographics